54.34
price down icon2.34%   -1.30
after-market アフターアワーズ: 53.70 -0.64 -1.18%
loading
前日終値:
$55.64
開ける:
$55.7
24時間の取引高:
528.46K
Relative Volume:
0.56
時価総額:
$1.03B
収益:
$90.12M
当期純損益:
$-276.06M
株価収益率:
-37.22
EPS:
-1.46
ネットキャッシュフロー:
$-193.47M
1週間 パフォーマンス:
-10.26%
1か月 パフォーマンス:
+12.79%
6か月 パフォーマンス:
+10,788%
1年 パフォーマンス:
+4,112%
1日の値動き範囲:
Value
$52.91
$56.49
1週間の範囲:
Value
$52.91
$62.95
52週間の値動き範囲:
Value
$0.432
$62.95

Nektar Therapeutics Stock (NKTR) Company Profile

Name
名前
Nektar Therapeutics
Name
セクター
Healthcare (1141)
Name
電話
(415) 482-5300
Name
住所
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA
Name
職員
61
Name
Twitter
@nektarnews
Name
次回の収益日
2025-03-12
Name
最新のSEC提出書
Name
NKTR's Discussions on Twitter

NKTR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NKTR
Nektar Therapeutics
54.34 1.06B 90.12M -276.06M -193.47M -1.46
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Nektar Therapeutics Stock (NKTR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-24 繰り返されました BTIG Research Buy
2025-06-24 繰り返されました H.C. Wainwright Buy
2025-04-11 アップグレード Jefferies Hold → Buy
2025-03-14 アップグレード Oppenheimer Perform → Outperform
2025-01-08 開始されました B. Riley Securities Buy
2024-12-10 開始されました H.C. Wainwright Buy
2024-11-04 開始されました Piper Sandler Overweight
2024-09-30 再開されました BTIG Research Buy
2024-06-28 開始されました Rodman & Renshaw Buy
2023-11-20 再開されました JP Morgan Underweight
2023-11-09 アップグレード TD Cowen Market Perform → Outperform
2023-05-10 アップグレード Jefferies Underperform → Hold
2023-02-24 ダウングレード Jefferies Hold → Underperform
2022-08-08 ダウングレード JP Morgan Neutral → Underweight
2022-05-31 再開されました Jefferies Hold
2022-04-18 ダウングレード Goldman Neutral → Sell
2022-03-15 ダウングレード Cowen Outperform → Market Perform
2022-03-15 ダウングレード Mizuho Buy → Neutral
2022-03-14 ダウングレード BTIG Research Buy → Neutral
2022-03-14 ダウングレード BofA Securities Neutral → Underperform
2022-03-14 ダウングレード Stifel Buy → Hold
2022-03-14 ダウングレード William Blair Outperform → Mkt Perform
2022-03-09 アップグレード Oppenheimer Perform → Outperform
2021-11-08 アップグレード The Benchmark Company Hold → Buy
2021-09-10 開始されました BofA Securities Neutral
2021-06-28 アップグレード Stifel Hold → Buy
2021-05-18 再開されました Goldman Neutral
2021-02-22 ダウングレード The Benchmark Company Buy → Hold
2021-01-06 開始されました Stifel Hold
2020-09-14 開始されました JP Morgan Neutral
2020-06-10 ダウングレード CFRA Hold → Sell
2020-05-12 繰り返されました H.C. Wainwright Neutral
2020-04-22 開始されました The Benchmark Company Buy
2020-03-30 アップグレード Goldman Sell → Neutral
2020-03-04 開始されました Barclays Overweight
2020-02-03 アップグレード Mizuho Neutral → Buy
2019-10-24 開始されました Oppenheimer Perform
2019-10-08 ダウングレード Goldman Buy → Sell
2019-08-09 ダウングレード JP Morgan Overweight → Neutral
2019-08-09 ダウングレード Jefferies Buy → Hold
2019-08-09 ダウングレード Mizuho Buy → Neutral
2019-03-15 開始されました SVB Leerink Mkt Perform
2018-12-13 開始されました Goldman Buy
2018-06-11 ダウングレード H.C. Wainwright Buy → Neutral
2018-06-04 繰り返されました H.C. Wainwright Buy
2018-04-20 開始されました Seaport Global Securities Buy
2018-04-13 再開されました Piper Jaffray Overweight
2018-04-06 繰り返されました Mizuho Buy
2018-04-02 再開されました H.C. Wainwright Buy
すべてを表示

Nektar Therapeutics (NKTR) 最新ニュース

pulisher
Oct 10, 2025

Why Nektar Therapeutics Stock Zoomed More Than 15% Higher Today - MSN

Oct 10, 2025
pulisher
Oct 10, 2025

Nektar Therapeutics' (NKTR) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

What MACD and RSI say about Nektar TherapeuticsJuly 2025 Fed Impact & Smart Money Movement Tracker - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Evaluating Nektar Therapeutics with trendline analysisJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Moderate to Severe Atopic Dermatitis Pipeline Drugs Insights Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight - The Globe and Mail

Oct 09, 2025
pulisher
Oct 09, 2025

How Nektar Therapeutics (ITH0) stock responds to job market shiftsNew Guidance & Reliable Price Breakout Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Sector ETF performance correlation with Nektar Therapeutics2025 Technical Patterns & AI Driven Price Predictions - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Quantitative breakdown of Nektar Therapeutics recent moveJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Gainplan LLC Buys New Shares in Nektar Therapeutics $NKTR - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Public Employees Retirement System of Ohio Sells 121,001 Shares of Nektar Therapeutics $NKTR - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

Nektar Therapeutics (NKTR): Examining Valuation After Breakthrough Eczema Drug Trial Results Spark Investor Interest - Sahm

Oct 07, 2025
pulisher
Oct 06, 2025

How Nektar Therapeutics (ITH0) stock reacts to weak economyDividend Hike & Real-Time Stock Movement Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

What analysts say about Nektar Therapeutics stockSwing Trading Watchlist & Build Wealth With Expert Timing Advice - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September - sharewise.com

Oct 05, 2025
pulisher
Oct 05, 2025

Real time social sentiment graph for Nektar TherapeuticsTrade Entry Report & Fast Exit and Entry Strategy Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is a relief rally coming for Nektar Therapeutics holdersTrade Entry Summary & Advanced Swing Trade Entry Plans - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

How analysts rate Nektar Therapeutics stock today2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Why Nektar Therapeutics (NKTR) Is Up 8.8% After Positive Phase 2b Rezpegaldesleukin Data at EADV - simplywall.st

Oct 03, 2025
pulisher
Oct 02, 2025

Nektar Therapeutics (NASDAQ:NKTR) Reaches New 52-Week HighTime to Buy? - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

Nektar Therapeutics stock hits 52-week high at 61.24 USD By Investing.com - Investing.com South Africa

Oct 02, 2025
pulisher
Oct 02, 2025

Nektar Therapeutics stock hits 52-week high at 61.24 USD - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

The biotech scorecard for the fourth quarter: 36 stock-moving events to watch - statnews.com

Oct 02, 2025
pulisher
Oct 02, 2025

BTIG Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $100 - 富途牛牛

Oct 02, 2025
pulisher
Oct 01, 2025

Building trade automation scripts for Nektar TherapeuticsJuly 2025 PostEarnings & Community Trade Idea Sharing Platform - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

Voya Investment Management LLC Raises Stock Holdings in Nektar Therapeutics $NKTR - MarketBeat

Oct 01, 2025
pulisher
Sep 29, 2025

Diffuse Large B Cell Lymphoma Pipeline Drugs Report 2025: Tracking Novel Therapies, Competitive Scenarios, and R&D Innovations Across Key Indications - Barchart.com

Sep 29, 2025
pulisher
Sep 29, 2025

Metastatic Renal Cell Carcinoma Pipeline 2025: Pioneering Clinical Developments by 40+ Global Leaders – DelveInsight | Novartis Pharmaceuticals, Vaccibody, SillaJen, Chongqing Precision Biotech - Barchart.com

Sep 29, 2025
pulisher
Sep 28, 2025

Nektar Therapeutics Hits New 52-Week High of $61.06, Up 229.74% - Markets Mojo

Sep 28, 2025
pulisher
Sep 28, 2025

Goldman Sachs Group Inc. Decreases Position in Nektar Therapeutics $NKTR - MarketBeat

Sep 28, 2025
pulisher
Sep 28, 2025

Parallel Advisors LLC Sells 14,767 Shares of Nektar Therapeutics $NKTR - MarketBeat

Sep 28, 2025
pulisher
Sep 28, 2025

Should you hold or exit Nektar Therapeutics nowJuly 2025 Sentiment & Stepwise Trade Execution Plans - newser.com

Sep 28, 2025
pulisher
Sep 26, 2025

Nektar Therapeutics (NASDAQ:NKTR) Trading 5.8% HigherWhat's Next? - MarketBeat

Sep 26, 2025

Nektar Therapeutics (NKTR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
大文字化:     |  ボリューム (24 時間):